IP Library › Granted Patent US 12,071,616
Granted Patent B2
US 12,071,616 · App. 17/193,652 · Granted Aug 27, 2024

RNA target enrichment or depletion of biological samples

Inventors: Brian O'Farrell (Watergrasshill, IE); Claire O'Connell (Stamullen, IE); Kaylyn Oshaben (Summerhill, PA); Daniel Appella (Bethesda, MD)
Assignees: Altratech Limited; The United States of America, as represented by the Secretary, Department of Health and Human Services
C12N15/1013C12Q1/6806
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,071,616
App. No.
17/193,652
Granted
Aug 27, 2024
Kind
B2
Abstract

A method of target enrichment or depletion from a sample with an analyte is described. A probe has one of a left-handed PNA pair and a targeting moiety, in which the left-handed PNA pair are a complementary pair of PNAs that are chiral and have a cyclic backbone modification that induces a left-handed helical structure. A capture surface has the other of the left-handed PNA pair; and the left-handed PNA pair bind to hybridize the probe to the capture surface, which may be a magnetic bead.

Claims (19)

1. A method of target enrichment in a sample, the method comprising the steps of:

introducing a probe comprising a left-handed PNA molecule linked to a capture moiety into a sample comprising target analyte;

capturing, with the capture moiety, the target analyte; and

binding the left-handed PNA molecule with a complementary PNA molecule comprising a left-handed chiral structure, the complementary PNA molecule being attached to a surface to thereby enrich for target analyte.

2. The method of claim 1 , wherein the surface comprises a bead.

3. The method of claim 2 , wherein the bead is a magnetic bead.

4. The method of claim 1 , wherein the surface comprises a fixed substrate.

5. The method of claim 1 , wherein the left-handed PNA molecule comprises a linker linking the left-handed PNA molecule to a targeting moiety.

6. The method of claim 1 , wherein the method further includes introducing a second probe into the sample, said second probe comprising a left-handed PNA, a targeting moiety, and a detection moiety.

7. The method of claim 6 , wherein the targeting moiety is a right-handed targeting PNA.

8. A method of claim 1 , wherein the capture moiety comprises an antibody or an antibody fragment.

9. The method of claim 1 , wherein the method is carried out at a temperature in the range of 18° C. to 80° C.

10. The method of claim 9 , wherein the method is carried out at a temperature of about 37° C.

11. The method of claim 1 , wherein the target analyte comprises RNA.

12. The method of claim 11 , wherein the RNA comprises 18s ribosomal RNA.

13. The method of claim 1 , wherein the surface comprises a surface of a bead, and said method further comprises after the binding step, heat the bead to provide a clean capture surface for re-use in a further assay.

14. The method of claim 1 , wherein the capture moiety comprises any one or more of an achiral or chiral PNA, a deoxyribonucleic acid, a ribonucleic acid, a glycol nucleic acid, a threose nucleic acid, a locked nucleic acid, a phosphorothioate oligonucleotide, a phosphorodiamidate morpholino oligomer, a protein, a peptide, a peptide or protein with unnatural amino acids, an enzyme, an antibody, a single domain antibody, an aptamer, a drug molecule, a small molecule, a chemical compound, a cell, or a combination of one or more of the above.

15. The method of claim 1 , wherein a detection moiety is linked with the left-handed PNA molecule, and the detection moiety includes one or more of the following: a fluorescent label, a luminescent label, a chromophore label, a chemiluminescent label, a radioactive label, an enzyme label, a visual label, a metallic label, a microsphere, a nanoparticle, a biotin label, an avidin label, a digoxigenin label, a cholesterol label, a dinitrophenyl label, a Horseradish peroxidase label, or a combination of one or more of the above.

16. The method of claim 1 , wherein the a left-handed PNA molecule comprises a linker, and the linker comprises a length of 1 to 120 atoms, and/or has one or some of the elements: C, N, O, S, P, and Si, and/or is in a chain that contains only one or a combination of the following bonds: a single bond, a double bond, a triple bond, an amide bond, an ester bond, a disulfide bond, an imino group, an ether bond, a thioether bond, and a thioester bond.

Assignments (1)
SECURITY INTEREST Recorded Nov 20, 2023
From: ALTRATECH LIMITED
To: CLARET EUROPEAN SPECIALTY LENDING COMPANY III, S.A R.L
Reel/Frame 065614/0588 →
Continuity (2)
Provisional Application 62986055 · Mar 6, 2020
Related Publication 20210277387A1 · Sep 9, 2021